FineMark National Bank & Trust’s KALA BIO KALA Stock Holding History

FineMark National Bank & Trust’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4	Closed	-$2K	–	417
2022 Q3	$2K	Hold	4	–	–	﹤0.01%	389
2022 Q2	$3K	Hold	4	–	–	﹤0.01%	418
2022 Q1	$14K	Buy	+4	New	+$10.5K	﹤0.01%	445
2021 Q4	–	Sell	-4	Closed	-$26K	–	473
2021 Q3	$26K	Hold	4	–	–	﹤0.01%	440
2021 Q2	$53K	Hold	4	–	–	﹤0.01%	438
2021 Q1	$67K	Hold	4	–	–	﹤0.01%	429
2020 Q4	$68K	Buy	+4	New	+$75.3K	﹤0.01%	409

Other funds holding KALA

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FineMark National Bank & Trust's KALA Position: Q4 2022 in Review

FineMark National Bank & Trust sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 4 shares — an estimated $2K sold.

FineMark National Bank & Trust first reported a position in KALA in Q4 2020 and held it in 7 quarters. The position peaked at $68K in Q4 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

FineMark National Bank & Trust reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
FineMark National Bank & Trust sold 4 KALA BIO shares in Q4 2022, an estimated $2K.
FineMark National Bank & Trust first reported a position in KALA BIO in Q4 2020 and held it in 7 quarters.
FineMark National Bank & Trust's KALA BIO position peaked at $68K in Q4 2020.
28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on FineMark National Bank & Trust's 13F filing for Q4 2022, filed 9 Feb 2023.